Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Go back to Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update| (NASDAQ: INTS) | Delayed: 4.11 +0.01 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.10 | 52 Week High | $ | |||
| Open | $4.07 | 52 Week Low | $ | |||
| Day High | $4.11 | P/E | N/A | |||
| Day Low | $4.06 | EPS | $ | |||
| Volume | 5,901 | |||||

